Target intelligence / Profile preview

Gut microbiota and epithelial cells

Molecular classification
Other
01

Overview

The "gut microbiota and epithelial cells" interface denotes a critical, dynamic interaction between the community of microorganisms inhabiting the gastrointestinal tract and the specialized epithelial cells lining the gut. Epithelial cells construct chemical and physical barriers, secrete immunological mediators, and interact with the microbiota through metabolites, cellular adhesion molecules, and signaling pathways. The crosstalk regulates immune responses, barrier integrity, and microbial composition, thereby influencing health and disease, including inflammatory, metabolic, and neoplastic conditions. This interface is a focus for emerging therapies such as probiotics, dietary modifications, and fecal microbiota transplantation, but cannot be considered a traditional pharmacological target (e.g., receptor, enzyme).

Other names
Gut microbiome and intestinal epithelial cellsGut microbiota–epithelial cell axisIntestinal microbiota–epithelial interfaceGut-epithelium crosstalk
02

Mechanism of action

Modulation of microbial composition (probiotics/antibiotics); Enhancement of barrier function (metabolites, SCFAs); Immune modulation (altering cytokine/chemokine output); Restoration of homeostasis (FMT, prebiotics)

03

Biological functions

Maintenance of intestinal homeostasisRegulation of epithelial barrier integrityImmune modulationHost defenseMetabolic regulationResponse to infection
04

Disease associations

Inflammatory bowel diseaseMetabolic disordersColorectal cancerInfectionChronic inflammatory disordersOther gastrointestinal diseases
05

Safety considerations

Disruption of microbiota composition (dysbiosis)Unintended immune activationTransmissible infections (from FMT)Allergic or inflammatory responses to microbiota-modulating interventions
06

Interacting drugs

Probiotics

4 more in the full profile.

07

Biomarkers

Short-chain fatty acids (SCFAs)Intestinal permeability markers (e.g., zonulin)Inflammatory cytokines (e.g., IL-22, IL-17)Bacterial composition profiles

Beyond the preview

Go deeper on Gut microbiota and epithelial cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota and epithelial cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call